Witek P, Mazur M, Witek J. Cushing’s disease: is pasireotide LAR a breakthrough in adjuvant therapy after unsuccessful surgery?. OncoReview [Internet]. 2017Dec.18 [cited 2024Nov.23];7(4(28):176-9. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/456